RUBELLA VIRUS IGG ANTIBODY

Rubella Virus IgG Antibody Test

The Rubella Virus IgG Antibody Test is a blood test used mainly to determine whether a person has immunity to rubella, also called German measles. Rubella-specific IgG antibodies usually develop after vaccination or previous natural infection and may remain detectable for many years, often for life.

Rubella is a contagious viral infection that commonly causes mild fever, rash, swollen lymph nodes, joint discomfort and tiredness. Some infected people may have no obvious symptoms. Although rubella is generally mild in children and non-pregnant adults, it can cause severe complications when infection occurs during pregnancy.

Rubella infection in early pregnancy can result in miscarriage, stillbirth, fetal death or Congenital Rubella Syndrome (CRS). CRS may cause hearing impairment, congenital heart disease, cataracts, developmental abnormalities and other serious complications. For this reason, determining rubella immunity is an important part of pre-pregnancy and prenatal healthcare.

The Rubella IgG test is commonly performed:

• Before pregnancy
• During the first antenatal visit
• To verify immunity in healthcare workers
• Before employment or admission where immunity documentation is required
• In people without reliable vaccination records
• After rubella vaccination when clinically indicated

The CDC recommends Rubella IgG serology for assessing rubella immunity, including before, during and after pregnancy. Rubella IgM should not be included in routine immunity screening because it is intended for suspected recent infection and may produce misleading results in asymptomatic individuals.

Understanding the Results

A Rubella IgG result is generally reported as:

• Positive or immune: Rubella-specific IgG antibodies are detected, usually indicating immunity due to vaccination or past infection.
• Negative or non-immune: No protective level of Rubella IgG is detected, suggesting susceptibility to rubella.
• Equivocal or borderline: The antibody level is near the laboratory cutoff and may require repeat testing, vaccination review or interpretation using the assay-specific reference range.

In the United States, an IgG concentration above 10 IU/mL is commonly used as the immunity cutoff, but laboratories must follow their own assay and manufacturer-specific reference values.

A positive Rubella IgG result does not determine exactly when infection or vaccination occurred. When recent primary infection is suspected, doctors may request Rubella IgM, IgG avidity testing, repeat serology or RT-PCR.

Benefits of the Test

• Assesses immunity to rubella.
• Supports preconception and antenatal screening.
• Helps identify individuals susceptible to infection.
• Provides laboratory evidence of immunity.
• Supports vaccination planning.
• Helps reduce the risk of congenital rubella syndrome.
• Requires only a simple blood sample.

Why Doctors Recommend This Test

Doctors may recommend Rubella IgG testing to determine whether a woman is protected before or during pregnancy, assess immunity in healthcare personnel or evaluate individuals without reliable vaccination records.

Preparation

No fasting or special preparation is generally required.

Inform the healthcare provider about:

• Pregnancy status
• Previous MMR or rubella vaccination
• Recent vaccination
• Previous rubella infection
• Immunosuppressive treatment
• Previous Rubella IgG results

A venous blood sample is collected, and serum is tested using an ELISA, CLIA or another validated immunoassay.

Reporting Time

Typically: 2–5 working days

Reporting time may vary depending on the laboratory method and workflow.

Who Should Take This Test?

This test may be recommended for:

• Women planning pregnancy
• Pregnant women during antenatal screening
• Healthcare workers
• Individuals without vaccination records
• People requiring proof of immunity
• Individuals with an equivocal previous result
• Women undergoing fertility treatment
• People at increased occupational exposure risk
• Individuals advised to review their vaccination status
• Anyone referred by a qualified healthcare professional